PositiveID to Exhibit at the Biodefense World Summit June 27-29
Jun 15, 2016 08:30:00 (ET)
PositiveID to Exhibit at the Biodefense World Summit June 27-29
Company to feature its molecular diagnostics and mobile labs businesses
DELRAY BEACH, Fla., June 15, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today that it will exhibit at the Biodefense World Summit from June 27-29, 2016, at the Hilton Baltimore in Baltimore, MD. PositiveID will feature its molecular diagnostics business including its Firefly Dx real-time pathogen detection system, and its E-N-G Mobile Systems ("ENG") mobile labs business.
PositiveID's Firefly Dx is a point-of-need ("PON"), handheld system designed to deliver molecular diagnostic results from a sample in less than 30 minutes, compared to hours or even days for a lab device, using real-time PCR (polymerase chain reaction) chemistry. Firefly's applications include PON, lab-quality, detection of pathogenic organisms; agricultural and food screening in both domestic sectors and developing countries; and detection of biological agents associated with weapons of mass destruction.
PositiveID's ENG business is a leader in engineering and producing its proprietary MobiLab(TM) Systems, mobile labs for biological, chemical, radiological and nuclear testing applications. Over 400 ENG MobiLabs are in operation throughout the world. ENG was the first company to install gas chromatography in a mobile lab, and is a pioneer in developing mobile platforms that allow standard laboratory-grade instruments to be operated successfully in the field.
About Biodefense World Summit 2016
The Knowledge Foundation's Second Annual Biodefense World Summit brings together leaders from government, academia, and industry for compelling discussions and comprehensive coverage on pathogen detection, sample prep technologies, point-of-care, and biosurveillance. Across the four-track event, attendees can expect exceptional networking opportunities in the exhibit hall, across panel discussions, and shared case studies with members of the biodefense community from technology providers to policy makers.
